Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-14

Clinical Trial Update: Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs [Phase 4]

View source ↗

Summary

Phase 4 trial comparing methenamine hippurate to trimethoprim for prevention of recurrent urinary tract infections; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methenamine Hippurate (Methenamine hippurate)
  • TRIMETHOPRIM (TRIMETHOPRIM)

Snippet

Sponsor: Endeavor Health | Conditions: Urinary Tract Infections, Recurrent | Phase 4 | Status: COMPLETED | Results posted: 2020-01-14